Literature DB >> 22327073

JAB1 is essential for B cell development and germinal center formation and inversely regulates Fas ligand and Bcl6 expression.

Selina Sitte1, Joachim Gläsner, Julia Jellusova, Florian Weisel, Martina Panattoni, Ruggero Pardi, André Gessner.   

Abstract

Jun activation domain-binding protein 1 (JAB1) regulates ubiquitin-dependent protein degradation by deneddylation of cullin-based ubiquitin ligases and, therefore, plays a central role in regulating proliferation and apoptosis. Because these processes are decisive for B cell development, we investigated JAB1 functions in B cells by establishing a mouse strain with a B cell-specific JAB1 deletion. We show that JAB1 is essential for early B cell development, because the ablation of JAB1 expression blocks B cell development between the pro-B and pre-B cell stages. Furthermore, JAB1 deletion leads to aberrant expression of the apoptosis-triggering protein Fas ligand in pro-B cells. Concomitant B cell-specific overexpression of the antiapoptotic protein Bcl2 partially reverses the block in B cell development; rescued JAB1-deficient B cells reach the periphery and produce protective class-switched Abs after Borrelia burgdorferi infection. Interestingly, B cell-rescued mice exhibit no germinal centers but a striking extrafollicular plasma cell accumulation. In addition, JAB1 is essential for Bcl6 expression, a transcriptional repressor required for germinal center formation. These findings identify JAB1 as an important factor in checkpoint control during early B cell development, as well as in fate decisions in mature Ag-primed B cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327073     DOI: 10.4049/jimmunol.1101455

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  VprBP Is Required for Efficient Editing and Selection of Igκ+ B Cells, but Is Dispensable for Igλ+ and Marginal Zone B Cell Maturation and Selection.

Authors:  Victoria L Palmer; Razia Aziz-Seible; Michele D Kassmeier; Mary Rothermund; Greg A Perry; Patrick C Swanson
Journal:  J Immunol       Date:  2015-07-06       Impact factor: 5.422

2.  The transcriptional co-regulator Jab1 is crucial for chondrocyte differentiation in vivo.

Authors:  Dongxing Chen; Lindsay A Bashur; Bojian Liang; Martina Panattoni; Keiko Tamai; Ruggero Pardi; Guang Zhou
Journal:  J Cell Sci       Date:  2012-11-30       Impact factor: 5.285

Review 3.  Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer.

Authors:  Yunbao Pan; Huiling Yang; Francois X Claret
Journal:  Cancer Biol Ther       Date:  2014-02-04       Impact factor: 4.742

Review 4.  Targeting Jab1/CSN5 in nasopharyngeal carcinoma.

Authors:  Yunbao Pan; Francois X Claret
Journal:  Cancer Lett       Date:  2012-08-04       Impact factor: 8.679

Review 5.  New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytes.

Authors:  Karen L Bunting; Ari M Melnick
Journal:  Curr Opin Immunol       Date:  2013-05-30       Impact factor: 7.486

6.  The transcriptional cofactor Jab1/Cops5 is crucial for BMP-mediated mouse chondrocyte differentiation by repressing p53 activity.

Authors:  Murali K Mamidi; William E Samsa; Lindsay A Bashur; Yuqing Chen; Ricky Chan; Brendan Lee; Guang Zhou
Journal:  J Cell Physiol       Date:  2021-01-03       Impact factor: 6.513

Review 7.  Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.

Authors:  Guohong Liu; Francois X Claret; Fuling Zhou; Yunbao Pan
Journal:  Front Pharmacol       Date:  2018-02-27       Impact factor: 5.810

8.  Cellular origin and pathophysiology of chronic lymphocytic leukemia.

Authors:  Marc Seifert; Ludger Sellmann; Johannes Bloehdorn; Frederik Wein; Stephan Stilgenbauer; Jan Dürig; Ralf Küppers
Journal:  J Exp Med       Date:  2012-10-22       Impact factor: 14.307

9.  The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo.

Authors:  William E Samsa; Murali K Mamidi; Lindsay A Bashur; Robin Elliott; Alexander Miron; Yuqing Chen; Brendan Lee; Edward M Greenfield; Ricky Chan; David Danielpour; Guang Zhou
Journal:  Oncogene       Date:  2020-05-10       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.